Professional Documents
Culture Documents
AND EXERCISE
Placebo effects have been recognised by medicine and by science, yet only
recently has systematic research begun to fully understand what they are and
how they work. Sport and exercise scientists started systematic research to
better understand the potential performance-enhancing effects of placebos as
well as how a range of treatments are used in sport, from nutritional supple-
ments to psychological interventions to sports medicine treatments. Placebo
Effects in Sport and Exercise synthesises this field of research of the influence
placebo effects have in sport and exercise.
This book brings together many of the world’s leading and emerging pla-
cebo effect researchers to help readers gain an understanding of core research
findings from within sports and exercise science as well as sport and exercise-
related contributions from experts in anthropology, medicine, and neurosci-
ence. Readers will gain an insight of what placebo and nocebo effects are, how
they might influence sport and exercise performance and outcomes, and how
they might significantly influence the effectiveness of performance and health
interventions.
The book investigates various practical and ethical implications for the sport
and exercise practitioner, student, and researcher to consider. Can a placebo
work if the athlete knows it’s a placebo? Should practitioners use placebos to
enhance performance? Can the use of placebos reduce doping? Are some
sports medicine treatments little more than placebos?
With the rapid growth of applied sports medicine, as well as the concept of
exercise as a mental health treatment in its own right, Placebo Effects in Sport
and Exercise is key reading for students and researchers of sport psychology as
well as those out in the field.
Philip Hurst, PhD, is a Senior Lecturer in Sport and Exercise Psychology at
the School of Psychology and Life Sciences at Canterbury Christ Church
University, UK.
Index 182
ILLUSTRATIONS
Figures
1.1 A psychosocial model of the placebo effect in the context of
sport (from: Raglin et al. 2020) 6
7.1 The foundation of generative models of the world following
Bayes’ theorem 74
7.2 The proposed effect of placebo on pain ratings based on
Bayesian theory 78
8.1 General subdivision of different altitude zones, and the
altitudes where we have data about placebo effects (3500 m,
4500 m, 5500 m) 87
8.2 Four physiological functions (ventilation, oxygenation,
circulation, perfusion), along with physical performance,
have been investigated by recording several physiological
parameters 90
8.3 The effects of placebo given for the first time, of oxygen,
and of placebo after oxygen preconditioning on minute
ventilation, blood pH, heart rate, PGE2, headache, fatigue
at 3500 m 91
8.4 Here performance is measured as the time needed to
complete 3000 steps on a stepper 94
9.1 Distinguishing the true effect of exercise on psychological
responses from non-specific effects requires the inclusion of
a placebo and no-treatment control group 101
11.1 Proposed model of working with beliefs effects when
delivering interventions 129
Illustrations ix
Tables
7.1 Glossary of terms used within predictive processing 76
9.1 The balanced placebo design is a model for observing
expectancy-related placebo effects that can be adapted
to studying psychological responses to exercise if a valid
exercise placebo is ever developed 107
13.1 Key topics, aims and tasks that facilitators can use to embed
into anti-doping interventions 149
CONTRIBUTORS
John S. Raglin
Introduction
The term Placebo – which in Latin translates as “I will please” – first appeared
in Psalm 116:9 in the 14th-century Latin Bible was actually a mistranslation of
the Hebrew for “I will walk” (Evans, 2003; Shapiro, 1968). Soon after the
term was used during the rise of the Black Death to describe hired as mourners
at funerals to fill in family members who had also succumbed to the plague or
were understandably absent. Subsequently, the term evolved into a common
insult to describe feigned sincerity.
The association of the term ‘placebo’ with medicine is generally believed to
have begun in the 18th century, but examples have been traced back more
than a millennia earlier to the writings of Galen (Guijarro, 2015). The most
celebrated historical application of a placebo to evaluate a medical intervention
also preceded its first appearance in a medical text. In 1784, Benjamin Franklin
and several other distinguished scientists, including Antoine Lavoisier, were
commissioned by King Louis XVI to investigate the controversial medical
practices of the physician Franz Mesmer. Mesmer had become a cause célèbre
among his wealthy Parisian patients by treating them for various maladies
using “animal magnetism,” an invisible force he claimed to have discovered.
Franklin’s commission utilised what is now regarded as the first placebo con-
trol, although it was not described as such in their report. They compared the
effects of objects treated with animal magnetism (“mesmerised”) with
untreated objects on patients who had previous experience with mesmerism,
and in some tests the patients wore blindfolds to prevent them from identify-
ing the treatment they were receiving. Their findings revealed that the patients
responded similarly whether exposed to mesmerised or untreated objects, and
DOI: 10.4324/9781003229001-1
2 John S. Raglin
even complete the test after complaining about “feeling terrible” because of
the side effects of the apparently high dose, 9 mg/kg, of caffeine. Paradoxically,
there are cases in which unpleasant side effects associated with an ergogenic
aid could exert a beneficial effect on performance. The athlete community is
well aware of less palatable aspects of many ergogenic aids – “If it tastes bad it
must be good for you” – and so unpleasant tastes or negative side effect may
be perceived as evidence of potent ingredients, thereby generating positive
expectations. Research has shown that that bitter tasting, but ergogenic inert
drinks are associated with improved sport performance (Gam et al., 2016).
A comprehensive understanding of placebo and nocebo effects must not only
acknowledge that the characteristics of placebos influence their efficacy, but
also recognise features of the psychosocial context in which they are adminis-
tered (Benedetti, 2013). These include the role of the provider of the placebo
(e.g., physician, therapist, or coach) and the setting in which the placebo is
provided (e.g., hospital, clinic, or stadium). This has led researchers to broaden
the definition of the placebo to acknowledge the influence of these factors.
A recent iteration based on this perspective has been created for the context of
sport in which a placebo is defined as: “the simulation of a proven ergogenic
aid within a psychosocial context” (Raglin et al., 2020). A sport-oriented sche-
matic of a psychosocial model of the placebo adapted from Benedetti (2013)
is presented in Figure 1.1.
FIGURE 1.1 A psychosocial model of the placebo effect in the context of sport.
(from: Raglin et al. 2020).
What are placebo effects? 7
Expectation
Expectation is the primary process behind the establishment of placebo effects.
Expectations have been described as predictions about future events (Kirsch,
1999) arising from existing experience, knowledge, or beliefs. Expectations
can be modified by factors such as suggestion, observational learning, and
conditioning. Some researchers have distinguished between expectations asso-
ciated with stimuli or with responses. Kirsch (1999) has described stimulus
expectancies as “anticipations of external events”, and response expectancies as
“predictions of nonvolitional responses”. A stimulus expectation in the context
of sport could involve the anticipated difficulty of a sporting event, whereas
the response expectancy would be the expectation that the perceived exertion
of the event will be lower or higher independent of performance. The term
‘belief’ has often been used synonymously with expectation, but many
researchers regard them to be largely independent constructs (DeGood &
Tait, 2001).
Conditioning
Placebo effects can also be established by classical conditioning. This occurs
when an unconditioned stimulus (e.g., medication in a capsule) that evokes an
unconditioned response (i.e., analgesia) becomes paired or associated with an
unconditioned stimulus (i.e., the capsule itself). The unconditioned stimulus
may include not only the capsule and its physical characteristics, such as size or
color, but also the situational cues or sensory features, such as the smell of
disinfectant, in the environment in which it was presented. These could include
the treatment context (a hospital), or characteristics of the person administer-
ing the capsule (a clinician wearing a white coat). Following a sufficient num-
ber of presentations, the conditioned stimulus (i.e., the capsule) can result in
analgesia (i.e., conditioned response) in the absence of any actual medication.
Most researchers contend that classical conditioning-mediated placebo effects
occur below the level of awareness and involve bodily changes that are not
perceived (i.e., unconscious), but there is evidence that conditioning can
change expectations (Meissner et al., 2011). Conversely, it has also been pro-
posed that some expectations are non-conscious and so some researchers
define conditioning as either explicit, resulting in conscious expectations or as
implicit and non-conscious conditioning which does not generate expecta-
tions (Stewart-Williams & Podd, 2004). These findings reinforce the difficulty
that can arise when attempting to determine what events led to the formation
of a placebo effect.
8 John S. Raglin
Summary
Throughout its history, the placebo effect has been almost entirely concep-
tualised and studied from the perspective of medicine and the ailing patient.
Sport-based studies with athletes were either ignored or regarded as a curi-
ous but incidental aspect of placebo research and theory. However, sport
researchers have begun to utilise the same technological and methodological
innovations that have revolutionised thinking about the placebo and its
effects in medicine. The findings of their work have not only documented the
contribution of placebo effects to sport performance but perhaps more
importantly, added to the broader understanding of placebos and placebo
mechanisms.
Research on the performance-enhancing effects of placebos has found that
their ergogenic benefits result from the potentiation of the same neurobio-
logical pathways as do placebos used in the context of medicine and illness.
This indicates that placebos have the ability not just to alleviate the symptoms
of patients suffering from medical conditions, but also to improve the func-
tioning and performance of adults who exhibit superior health and physical
conditioning. It is evident that some of these improvements stem from the
reduction of pain or fatigue as do many medical placebos, but there are likely
neurobiological processes which are unique to the context of sport. For
instance, perception of exertion is often conflated with fatigue in the medical
literature, but research indicates it is only moderately correlated with fatigue
as well as pain,, and the sensation of exertion has been shown to involve
unique neurobiological processes (Williamson et al., 2001). Additionally,
high levels of felt energy or vigor are associated with superior athletic perfor-
mance and aid in the resistance to sport maladies such as the overtraining
syndrome (Raglin, 2007), and there is growing evidence these positive feel-
ings are independent from and evoke different neurological activity than
those associated with fatigue (Dishman et al., 2010; Loy et al., 2018). Finally,
consistent with research involving medical placebos, athletes exhibit consider-
able individual differences in their responses to placebos. Information reveal-
ing that athletes are either similar or different from participants in medical
studies in respect of the characteristics that influence placebo or nocebo
responsiveness would enhance our general understanding of the placebo
effect, and potentially lead to more effective practices in enhancing placebo
effects in clinical practice.
The growth in scope and sophistication of sport placebo research has
begun to draw from the periphery into the mainstream of the general field of
placebo studies. It is now evident that many of the unanswered questions
about sport placebos will have important implications to our greater theo-
retical understanding of placebos and their potential applications in clinical
practice.
What are placebo effects? 9
References
Beecher, H. K. (1955). The powerful placebo. Journal of the American Medical
Association, 159(17), 1602–1606.
Beedie, C., Benedetti, F., Barbiani, D., Camerone, E., Lindheimer, J., & Roelands, B.
(2020). Incorporating methods and findings from neuroscience to better under-
stand placebo and nocebo effects in sport. European Journal of Sport Science, 20(3),
313–325.
Beedie, C. J., & Foad, A. J. (2009). The placebo effect in sports performance: A brief
review. Sports Medicine, 39, 313–329.
Beedie, C. J., Stuart, E. M., Coleman, D. A., & Foad, A. J. (2006). Placebo effects of
caffeine on cycling performance. Medicine and Science in Sports and Exercise,
38(12), 2159.
Benedetti, F. (2013). Placebo and the new physiology of the doctor-patient relation-
ship. Physiological Reviews, 93(3), 1207–1246.
Benedetti, F., Pollo, A., Lopiano, L., Lanotte, M., Vighetti, S., & Rainero, I. (2003).
Conscious expectation and unconscious conditioning in analgesic, motor, and hor-
monal placebo/nocebo responses. Journal of Neuroscience, 23(10), 4315–4323.
Carlino, E., Piedimonte, A., & Frisaldi, E. (2014). The effects of placebos and nocebos
on physical performance. Placebo, 149–157.
DeGood, D. E., & Tait, R. C. (2001). Assessment of pain beliefs and pain coping. In
D. Turk & R. Melzack (Eds.), Handbook of pain assessment. The Guilford Press.
Dishman, R. K., Thom, N. J., Puetz, T. W., O’Connor, P. J., & Clementz, B. A. (2010).
Effects of cycling exercise on vigor, fatigue, and electroencephalographic activity
among young adults who report persistent fatigue. Psychophysiology, 47(6),
1066–1074.
Evans, D. (2003). Placebo: The belief effect. HarperCollins London.
Feldman, S. R., Liguori, A., Kucenic, M., Rapp, S. R., Fleischer Jr, A. B., Lang, W., &
Kaur, M. (2004). Ultraviolet exposure is a reinforcing stimulus in frequent indoor
tanners. Journal of the American Academy of Dermatology, 51(1), 45–51.
Fent, R., Rosemann, T., Fässler, M., Senn, O., & Huber, C. A. (2011). The use of pure
and impure placebo interventions in primary care-a qualitative approach. BMC
Family Practice, 12(1), 1–7.
Franklin, B. (1784). The papers of Benjamin Franklin: March 1 through August 15, 1784
(Vol. 42). Yale University Press.
Gam, S., Guelfi, K. J., & Fournier, P. A. (2016). New insights into enhancing maximal
exercise performance through the use of a bitter tastant. Sports Medicine, 46,
1385–1390.
Guijarro, C. (2015). A history of the placebo. Neuroscience History, 2015(2), 68–80.
Hollister, L. (1960). Placebology: Sense and nonsense. Current Therapeutic Research,
Clinical and Experimental, 2, 477–483.
Hurst, P., Schipof-Godart, L., Szabo, A., Raglin, J., Hettinga, F., Roelands, B., Lane,
A., Foad, A., Coleman, D., & Beedie, C. (2020). The placebo and nocebo effect on
sports performance: A systematic review. European Journal of Sport Science, 20(3),
279–292.
Kaptchuk, T. J., Kerr, C. E., & Zanger, A. (2009). Placebo controls, exorcisms, and the
devil. The Lancet, 374(9697), 1234–1235.
Kienle, G. S., & Kiene, H. (1997). The powerful placebo effect: Fact or fiction? Journal
of Clinical Epidemiology, 50(12), 1311–1318.
10 John S. Raglin